M. Kraus & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Hold
901
– – 0.28% 41
2026
Q2
$1.08M Sell
901
-25
-3% -$25.5K 0.29% 41
2026
Q1
$852K Hold
926
– – 0.25% 42
2025
Q4
$995K Sell
926
-34
-4% -$32.5K 0.28% 44
2025
Q3
$732K Hold
960
– – 0.2% 49
2025
Q2
$748K Sell
960
-25
-3% -$19.4K 0.22% 49
2025
Q1
$814K Hold
985
– – 0.25% 45
2024
Q4
$760K Hold
985
– – 0.23% 46
2024
Q3
$873K Hold
985
– – 0.26% 42
2024
Q2
$892K Sell
985
-29
-3% -$23.2K 0.27% 41
2024
Q1
$789K Sell
1,014
-15
-1% -$10.7K 0.24% 42
2023
Q4
$600K Sell
1,029
-59
-5% -$34.4K 0.2% 46
2023
Q3
$584K Hold
1,088
– – 0.21% 46
2023
Q2
$510K Sell
1,088
-5
-0.5% -$2.1K 0.17% 48
2023
Q1
$375K Sell
1,093
-4
-0.4% -$1.35K 0.13% 58
2022
Q4
$401K Buy
1,097
+406
+59% +$144K 0.15% 55
2022
Q3
$223K Buy
+691
New +$219K 0.09% 65

Other funds holding LLY

M. Kraus & Co's LLY Position: Q3 2026 in Review

M. Kraus & Co held its Eli Lilly (LLY) position steady in Q3 2026 at 901 shares worth $1.04M. The position accounts for 0.28% of the portfolio, ranked #41.

M. Kraus & Co first reported a position in LLY in Q3 2022 and has held it in 17 quarters since. The position peaked at $1.08M in Q2 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • M. Kraus & Co held 901 shares of Eli Lilly worth $1.04M as of Q3 2026.
  • M. Kraus & Co left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.28% of M. Kraus & Co's portfolio in Q3 2026, its #41 holding.
  • M. Kraus & Co first reported a position in Eli Lilly in Q3 2022 and has held it in 17 quarters since.
  • M. Kraus & Co's Eli Lilly position peaked at $1.08M in Q2 2026.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on M. Kraus & Co's 13F filing for Q3 2026, filed 20 Oct 2026.